María Teresa Borrello
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
María Teresa Borrello has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Nelson Dusetti
Centre de Recherche en Cancérologie de Marseille (CRCM), Unité 1068, Institut National de la Santé et de la Recherche Médicale, F-13009 Marseille, France
22 shared publications Analía Meilerman Abuelafia
21 shared publications- Eduardo Chuluyan
Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
21 shared publications Emmanuel Telle
21 shared publicationsJulie Roques
21 shared publicationsMartin Bigonnet
21 shared publications
Latest Publications
- Top Cited PapersOpen Access
The Skin Microbiome Revolution: The Science and Challenges of Prebiotics, Probiotics, and Postbiotics in Skincare
The skin microbiome comprises a diverse community of bacteria, fungi, and archaea, all of which play a foundational role in maintaining skin health, immune tolerance, and barrier integrity. Recent advances in cosmetic science focus on the skin microbiome through the incorporation of prebiotics, probiotics and postbiotics in topical skincare formulations. This review critically examines the scientific understanding of the skin microbiome, explores the mechanisms and extractions of key “biotics” ingredients, and evaluates the clinical and regulatory landscape surrounding their use in the cosmetic industry. Despite promising scientific data and early clinical findings, there are notable challenges, including limited robust in vivo evidence, regulatory ambiguity, difficulties in formulation, and inconsistent definition and marketing claims. Regulatory harmonisation and the development of standardised testing protocols are necessary to fill the gap in today’s research and to maximise the benefits of “biotics” in the cosmetic industry.
Top Cited PapersOpen AccessThe Skin Microbiome Revolution: The Science and Challenges of Prebiotics, Probiotics, and Postbiotics in Skincare
The skin microbiome comprises a diverse community of bacteria, fungi, and archaea, all of which play a foundational role in maintaining skin health, immune tolerance, and barrier integrity. Recent advances in cosmetic science focus on the skin microbiome through the incorporation of prebiotics, probiotics and postbiotics in topical skincare formulations. This review critically examines the scientific understanding of the skin microbiome, explores the mechanisms and extractions of key “biotics” ingredients, and evaluates the clinical and regulatory landscape surrounding their use in the cosmetic industry. Despite promising scientific data and early clinical findings, there are notable challenges, including limited robust in vivo evidence, regulatory ambiguity, difficulties in formulation, and inconsistent definition and marketing claims. Regulatory harmonisation and the development of standardised testing protocols are necessary to fill the gap in today’s research and to maximise the benefits of “biotics” in the cosmetic industry.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Enhancing the Cosmetic Potential of Vitex trifolia L. Extract: An Approach of Aqueous–Polyol Mixture in Ultrasound‐Assisted Extraction for Wound‐Healing and Antioxidant Properties
This research aimed to optimize solvent concentration and extraction conditions for total phenolic content (TPC) and antioxidant activity (DPPH and ABTS) in VT leaves using ultrasound‐assisted extraction (UAE). A simplex‐lattice design incorporating an aqueous–polyol mixture and a central composite design (CCD) within response surface methodology (RSM) were utilized. The optimal solvent composition was determined to be 37.32% w/v aqueous, 26.87% w/v glycerin, and 35.81% w/v butylene glycol, with an ideal solvent‐to‐sample ratio of 33.21:1 mL/g and an extraction duration of 15 min. UAE with the aqueous–butylene glycol–glycerin (U‐BG) mixture significantly enhanced TPC and antioxidant activity compared to conventional maceration methods ( p < 0.05). Key bioactive compounds identified included Orientalol E, (+)‐15‐Beyeren‐3‐one, and petunidin‐3‐O‐arabinoside. The U‐BG extract exhibited higher cell viability and antioxidant activity compared with ethanol‐based extracts and demonstrated strong wound‐healing properties, achieving effective wound closure within 20 h. This study underscores the potential of aqueous–polyol extraction for enhancing bioactive compound recovery, offering sustainable solutions for the cosmetic and pharmaceutical industries.
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Open AccessEnhancing the Cosmetic Potential of Vitex trifolia L. Extract: An Approach of Aqueous–Polyol Mixture in Ultrasound‐Assisted Extraction for Wound‐Healing and Antioxidant Properties
This research aimed to optimize solvent concentration and extraction conditions for total phenolic content (TPC) and antioxidant activity (DPPH and ABTS) in VT leaves using ultrasound‐assisted extraction (UAE). A simplex‐lattice design incorporating an aqueous–polyol mixture and a central composite design (CCD) within response surface methodology (RSM) were utilized. The optimal solvent composition was determined to be 37.32% w/v aqueous, 26.87% w/v glycerin, and 35.81% w/v butylene glycol, with an ideal solvent‐to‐sample ratio of 33.21:1 mL/g and an extraction duration of 15 min. UAE with the aqueous–butylene glycol–glycerin (U‐BG) mixture significantly enhanced TPC and antioxidant activity compared to conventional maceration methods ( p < 0.05). Key bioactive compounds identified included Orientalol E, (+)‐15‐Beyeren‐3‐one, and petunidin‐3‐O‐arabinoside. The U‐BG extract exhibited higher cell viability and antioxidant activity compared with ethanol‐based extracts and demonstrated strong wound‐healing properties, achieving effective wound closure within 20 h. This study underscores the potential of aqueous–polyol extraction for enhancing bioactive compound recovery, offering sustainable solutions for the cosmetic and pharmaceutical industries.
- Open Access
Traditional Knowledge Evolution over Half of a Century: Local Herbal Resources and Their Changes in the Upper Susa Valley of Northwest Italy
Susa Valley, located in the Italian Western Alps, has served as a meeting point for cultural, spiritual, and commercial exchange for a long period of history. The valley’s role as one of the main connecting routes between south and southwestern Europe resulted in its acquisition of a rich traditional ecological knowledge. However, like other Italian mountainous valleys, this valley has suffered from abandonment and depopulation in the past 50 years. Our study aims to investigate the current ethnobotanical medicinal knowledge in the valley and to compare our findings with a study conducted over 50 years ago in the same area. In 2018, we conducted 30 in-depth semi-structured interviews on medicinal plants and food-medicines used in the Susa Valley. We documented 36 species, of which 21 species were used for medical purposes and 15 species were used as food-medicine. The comparison with the previous study on medicinal herbs conducted in 1970 in the valley demonstrated a significant decrease in both the knowledge and use of medicinal plants, which could be attributed to socioeconomic, cultural, and possibly environmental changes that occurred in the past half-century. Our study highlights several promising species for future use as nutraceuticals, food, and medicinal products, such as Taraxacum officinale, Urtica dioica, and Artemisia genipi.
Open AccessTraditional Knowledge Evolution over Half of a Century: Local Herbal Resources and Their Changes in the Upper Susa Valley of Northwest Italy
Susa Valley, located in the Italian Western Alps, has served as a meeting point for cultural, spiritual, and commercial exchange for a long period of history. The valley’s role as one of the main connecting routes between south and southwestern Europe resulted in its acquisition of a rich traditional ecological knowledge. However, like other Italian mountainous valleys, this valley has suffered from abandonment and depopulation in the past 50 years. Our study aims to investigate the current ethnobotanical medicinal knowledge in the valley and to compare our findings with a study conducted over 50 years ago in the same area. In 2018, we conducted 30 in-depth semi-structured interviews on medicinal plants and food-medicines used in the Susa Valley. We documented 36 species, of which 21 species were used for medical purposes and 15 species were used as food-medicine. The comparison with the previous study on medicinal herbs conducted in 1970 in the valley demonstrated a significant decrease in both the knowledge and use of medicinal plants, which could be attributed to socioeconomic, cultural, and possibly environmental changes that occurred in the past half-century. Our study highlights several promising species for future use as nutraceuticals, food, and medicinal products, such as Taraxacum officinale, Urtica dioica, and Artemisia genipi.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a survival rate less than 5%. Multiple chemotherapeutic drugs have been tested to improve patient prognosis; however, the clinical efficacy of these treatments is low. One of the most controversial family of drugs are the proteasome inhibitors, which have displayed promising effects in preclinical studies, but low clinical performance. Here, we unravel a specific transcriptomic signature that discriminates a subgroup of patients sensitive to the proteasome inhibitor carfilzomib.Experimental Design:First, we identified a subpopulation of PDAC-derived primary cells cultures (PDPCC) sensitive to the proteasome inhibitor carfilzomib. Then, we selected a transcriptomic signature that predicts carfilzomib chemosensitivity using independent component analysis on the transcriptome of PDPCC. Finally, we validated the signature in an independent cohort of PDAC biopsy-derived pancreatic organoids.Results:Sensitive phenotype was characterized by a high expression of genes related with a cornified/squamous pathway and a downregulation of epithelial–mesenchymal transition genes. Interestingly, carfilzomib-sensitive transcriptomic profile did not show any association with the proteasome activity but strongly correlates with ATF4 and CHOP expression, which are key markers of the unfolded protein response and critical to trigger the cell death program. Concordantly, sensitive phenotype showed a high level of the de novo RNA and protein synthesis compared with the resistant one and, most important, cell death induced by carfilzomib is dependent of the translational activity.Conclusions:We demonstrate the existence of a carfilzomib-sensitive PDAC subgroup with a specific transcriptomic phenotype that could explain the biological reason for this responsiveness.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib
Purpose:Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a survival rate less than 5%. Multiple chemotherapeutic drugs have been tested to improve patient prognosis; however, the clinical efficacy of these treatments is low. One of the most controversial family of drugs are the proteasome inhibitors, which have displayed promising effects in preclinical studies, but low clinical performance. Here, we unravel a specific transcriptomic signature that discriminates a subgroup of patients sensitive to the proteasome inhibitor carfilzomib.Experimental Design:First, we identified a subpopulation of PDAC-derived primary cells cultures (PDPCC) sensitive to the proteasome inhibitor carfilzomib. Then, we selected a transcriptomic signature that predicts carfilzomib chemosensitivity using independent component analysis on the transcriptome of PDPCC. Finally, we validated the signature in an independent cohort of PDAC biopsy-derived pancreatic organoids.Results:Sensitive phenotype was characterized by a high expression of genes related with a cornified/squamous pathway and a downregulation of epithelial–mesenchymal transition genes. Interestingly, carfilzomib-sensitive transcriptomic profile did not show any association with the proteasome activity but strongly correlates with ATF4 and CHOP expression, which are key markers of the unfolded protein response and critical to trigger the cell death program. Concordantly, sensitive phenotype showed a high level of the de novo RNA and protein synthesis compared with the resistant one and, most important, cell death induced by carfilzomib is dependent of the translational activity.Conclusions:We demonstrate the existence of a carfilzomib-sensitive PDAC subgroup with a specific transcriptomic phenotype that could explain the biological reason for this responsiveness.